 |
分子醫學中心 |
|
(執行中)
| 計畫主持人 | 計畫題目 | Title of Proposal | 補助機關Funding Agency |
| 洪明奇 Mien-Chie Hung |
幹細胞之訊息途徑及表基因調控-探討胚胎幹細胞中GSK3beta及p38 kinase對EZH2的調控以及ErbB family及miRNA在胚胎幹細胞之生長及分化之調控(Project 5) | Signal pathways and epigenetic regulation of stem cells | 國科會 NSC |
| 洪明奇 Mien-Chie Hung |
幹細胞之訊息途徑及表基因調控-行政核心計畫(Core A) | Administrative Core | 國科會 NSC |
| 洪明奇 Mien-Chie Hung |
肺癌治療之新穎策略的研發 | Development of novel strategies for lung cancer therapy | 衛生署 DOH |
| 洪明奇 Mien-Chie Hung |
建置癌症卓越研究體系--乳癌 | CMUH Cancer Research Certer of Excellence | 衛生署 DOH |
| 李龍緣 Long-Yuan Li |
細胞核內致癌蛋白質ErbB-2對腫瘤發展形成和癌轉移影響之探討 | The Effects of Nuclear ErbB-2 on Tumor Progression and Metastasis | 國衛院 NHRI |
| 李龍緣 Long-Yuan Li |
幹細胞之訊息途徑及表基因調控-研究探討間質幹細胞之脂肪細胞與骨骼細胞分化之分子機轉(Project 3) | Adipocyte and osteoblast differentiation of mesenchymal stem cells | 國科會 NSC |
| 謝嘉玲 Chia-Ling Hsieh |
探討細胞吸附分子L1在前列腺癌轉移的生物機制與治療之可行性 | L1 cell adhesion molecule in prostate cancer metastasis: biology and therapeutics application |
國科會 NSC |
| 謝嘉玲 Chia-Ling Hsieh |
間質幹細胞腫瘤趨向性之機制探討及在標靶基因治療的應用 | Mesenchymal stem cells tumor tropism and its application in targeted gene therapy | 國科會 NSC |
| 余永倫 Yung-Luen Yu |
癌細胞增生中致癌蛋白EGFR在細胞核內功能之探討(乳癌) | The nuclear function of EGF receptor in cancer cell proliferation | 國科會 NSC |
| 余永倫 Yung-Luen Yu |
幹細胞之訊息途徑及表基因調控-人類間質幹細胞的神經分化之分子機制研究(Project 4) | Molecular Mechanisms of Neuron Differentiation in Human Mesenchymal Stem Cells | 國科會 NSC |
| 宋賢穎 Shian-Ying Sung |
評估以ADAM9基因治療結合放射線治療對前列腺癌骨轉移之研究 | ADAM9 gene targeting concomitantly with radiation therapy for the effective treatment of prostate cancer bone metastasis |
國科會 NSC |
| 宋賢穎 Shian-Ying Sung |
研究趨化因子接受器，CCRL2，促使惡性前列腺癌骨轉移之機轉 |
Functional Studies of Orphan Chemokine Receptor, CCRL2, in Prostate Cancer Bone Metastasis | 國衛院 NHRI |
| 蘇振良 Jen-Liang Su |
探索E1A在抑制腫瘤發展及癌轉移之分子機制 (乳癌) | Study the novel molecular mechanisms of E1A-mediated tumor supression and metastasis | 國衛院 NHRI |
| 蘇振良 Jen-Liang Su |
探討肺癌細胞腦部轉移之分子機轉 | Novel signal pathways involved in lung cancer brain metastasis | 衛生署 DOH |
| 蘇振良 Jen-Liang Su |
研究C型血管內皮細胞生長因子在肺癌中之新穎功能及相關的分子機轉 | Study the novel functions and molecular mechanisms of VEGF-C in lung cancer | 國科會 NSC |
| 黃偉謙 Wei-Chien Huang |
HER-2核易位與癌細胞對EGFR抑制劑產生耐藥性之探討(乳癌) | Role of nuclear HER-2 in acquired resistance to EGFR inhibitors | 國科會 NSC |
| 黃偉謙 Wei-Chien Huang |
IKK alpha於細胞核內參與腫瘤發展及轉移之探討(乳癌, 肝癌) | Novel roles of nuclear IKKalpha in tumor progression and metastasis | 國衛院 NHRI |
| 黃偉謙 Wei-Chien Huang |
鈉葡萄糖共轉運載體影響肺癌表皮生長因子受體標靶治療效能之研究 | The role of sodium/glucose transporter1 in EGFR-targeted therapy of lung cancers | 國科會 NSC |
| 劉哲育 Jer-Yuh Liu |
E1k-1和MZF-1轉錄因子參與調控癌瘤細胞中蛋白激酵素C alpha基因表現之研究 | The investigation of the involvement of the transcription factors E1k-1 and MZF-1 in the modulation of protein kinase C alpha gene expression in cancer cells | 國科會 NSC |
| 佘玉萍 Yuh-Pyng Sher |
標靶型基因治療法用於肺癌治療上所誘發的抗癌免疫力之機轉的探討 | The mechanism of anti-tumor immunity elicited by targeted gene therapy in lung cancer treatment | 國科會 NSC |
(2010-0608更新)